Our next generation lung cancer cell models have a clear ancestral link to defined patient tumors, and elucidates patient-to-patient differences before getting into clinical trials.

Jacket, Pincer, Throne, Bastion and Boulder delivers the reproducibility and clinical relevance required to improve R&D success for lung cancer. They represent a major breakthrough relative to existing cell lines with respect to:

• Authenticated heritage
• Patient specificity
• Stability
• Faithful heterogeneity and relevance
• Accompanying documentation
• Characterized response to established therapies

In combination with Cellaria’s scientific know-how, the patient-specific cell model directly mirrors the established benefits of our existing portfolio of cell models. 

Identifying patient-to-patient differences in drug response to a range of standard chemotherapeutics.

We have identified a panel of drugs that represent a relevant breadth of established, baseline treatment choices, enabling the critical evaluation of drug response differences in our patient cohorts.

The study uses the Genomics of Drug Sensitivity in Cancer (GDSC) database to establish a context for the individual drug response of our patient-specific models.

Explore the baseline drug response data for our lung cancer patient cohort, along with drug response data from the GDSC database, by downloading our report now.

Download Our Report Now

In combination with Cellaria’s scientific know-how, the patient-specific cell model directly mirrors the established benefits of our existing portfolio of cell models.

Don’t see the patient-specific cell line you need? Then take a look at our custom cell line development services.

Contextual Disease Data

We provide comprehensive proteomics profiles of each cell model, with details of how the performance data compares to other known patients, across multiple disease states. This enables scientists to know, based on data, how their drug will potentially perform in specific patient populations and empowers precision therapeutics programs.

Learn more about how we Characterize and authenticate our models.